Two hepatotropic viruses, hepatitis B and C viruses, are known to caus
e hepatocellular carcinoma in humans. Hepatocarcinogenesis is a comple
x, stepwise process that evolves over several to many years and precis
ely how hepatitis viruses contribute to malignant transformation of he
patocytes is uncertain. Hepatitis B vrus is integrated into cellular D
NA in the great majority of hepatitis B virus-related hepatocellular c
arcinomas, whereas replicative intermediates of hepatitis C virus do n
ot insert into chromosomal DNA, making it likely that different pathog
enetic mechanisms operate with the two viruses. Indeed, evidence is mo
unting that both direct and indirect carcinogenic mechanisms, and ofte
n the two together, are involved in virus-induced hepatocellular carci
noma. In addition, evidence is now available that hepatitis B and C vi
ruses interact synergistically in the pathogenesis of hepatocellular c
arcinoma. Animal models, - other members of the Hepadnaviridae family
that cause tumors in their respecitve animal hosts, and transgenic mic
e into which the sequences of hepatitis B virus DNA have been inserted
- are proving useful in elucidating putative mechanisms of hepatitis
B virus-related hepatocarcinogenesis. Whatever the genesis of hepatiti
s virus-induced hepatocellular carcinoma, it is clear that hepatitis v
iruses do not act alone but in conjunction with other environmental ca
rcinogens and a number of host factors.